<!DOCTYPE html>
<html>
<head>
	<meta charset="UTF-8">
	<title>Peking University Pharmacometrics Group</title>
	<link rel="stylesheet" href="css/style.css" tppabs="http://www.poppk-beijing.org/css/style.css" type="text/css">
</head>
<body>
	<div class="background">
		<div class="page">
			<a href="home.html" tppabs="http://www.poppk-beijing.org/home.html" id="logo">Peking University Pharmacometrics Group</a>
			<div class="sidebar">
			<ul>
					<li>
						<a href="home.html" tppabs="http://www.poppk-beijing.org/home.html">Home</a>
					</li>
					<li>
						<a href="PPPEC.html" tppabs="http://www.poppk-beijing.org/PPPEC.html">PMxEC</a>
					</li>
					<li>
						<a href="education.html" tppabs="http://www.poppk-beijing.org/education.html">Education</a>
					</li>
					<li>
						<a href="research.html" tppabs="http://www.poppk-beijing.org/research.html">Research</a>
					</li>
					<li>
						<a href="group.html" tppabs="http://www.poppk-beijing.org/group.html">Group</a>
					</li>
					<li class="selected">
						<a href="publication.html" tppabs="http://www.poppk-beijing.org/publication.html">Publication</a>
					</li>
                    <li>
						<a href="cooperation.html" tppabs="http://www.poppk-beijing.org/cooperation.html">Cooperation</a>
					</li>
                    <li>
						<a href="TDM.html" tppabs="http://www.poppk-beijing.org/TDM.html">TDM</a>
					</li>
                     <li>
						<a href="photo.html" tppabs="http://www.poppk-beijing.org/photo.html">Photo</a>
					</li>
                     <li>
						<a href="home-cn.html" tppabs="http://www.poppk-beijing.org/home-cn.html">中文</a>
					</li>
              </ul>
				<div class="first">
					<div>
					  <h3>Prof. Wei Lu</h3>
							<img src="images/ProfLu2.jpg" tppabs="http://www.poppk-beijing.org/images/ProfLu2.jpg" alt="">
						<p>
							Director of Peking Univerisity / Pfizer Pharmacometrics Education Center</p>
					</div>
				</div>
				<div>
					<div>
					<h3>News</h3>
                      <p><strong>The 4th International Symposium in Quanti-<br>tative Pharmacology</strong><br>November 1-3, 2013, Beijing, China
                      </p>
						<a href="javascript:if(confirm(%27http://www.htbr.cn/isqp/  \n\nThis file was not retrieved by Teleport Pro, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?%27))window.location=%27http://www.htbr.cn/isqp/%27" tppabs="http://www.htbr.cn/isqp/"><img src="images/ISQP4_1.jpg" tppabs="http://www.poppk-beijing.org/images/ISQP4_1.jpg" alt=""></a>
<ul style="font-size:10px">
<div align="justify"> The 4th International Symposium Quantitative Pharmacology in Drug Development and Regulation (ISQP), held at Tiantan Hotel in Beijing from November 1st to 3rd 2013, was a huge success. This symposium was jointly organized by Mathematical Pharmacology Professional Committee of China (Chinese Pharmacological Society), School of Pharmaceutical Sciences of Peking University, and State Key Laboratory of Natural and Biomimetic Drugs (Peking University), and supported by International Society of Pharmacometrics (ISoP). With over 300 experts (including President-Elect and several senior members of ISoP, Vice Presidents and other senior management from Pfizer, Janssen R&D, Roche, etc.) in drug regulatory authorities, industry and academia from China, US, UK, France, Belgium, New Zealand, India, Japan and other countries and regions in attendance, the opportunities, challenges, hot topics, latest academic thoughts and research findings in Pharmacometrics were discussed in depth.
</div>
<div align="justify">Prof. Wei, Lu, Chairman of the Symposium, Prof. Junyi Liu, Dean of the School of Pharmaceutical Sciences of PKU, Prof. Ruiyuan Sun, Honorary Chairman of the Symposium, and Dr. Sharma Amarnath, Vice President of Quantitative Sciences in Janssen R&D gave a warm welcome speech in turn to kick off the meeting.
</div>
<div align="justify">The conference program consisted of invited plenary lectures and poster sessions of unsolicited contributions. 40 invited scholars and experts from China and abroad delivered excellent speeches on: (1) Impact of Model-based Methods on Drug Development Strategy and Clinical Trial Design, (2) Application and Emerging Technologies of Quantitative Pharmacology, (3) PK/PD and Disease Progression Modeling, Discovery of Biomarker and its Quantitative Analysis, (4) Therapeutic Drug Monitoring and Model-based Dosing Individualization, (5) Clinical Trial Design and PK/PD Modeling and Simulation Case Studies in Drug Development, (6) Ethnicity Sensitivity Assessment and Clinical Bridging: Quantitative Design and Case Study, (7) Model-based Meta-analysis (MBMA), (8) Application of Model Based Approaches for the Development of Biological Drugs. Many young and middle-aged researchers with vigor and vitality also exhibited recent research findings in Pharmacometrics.
</div>
<div align="justify">Prof. Wei Lu was elected to serve for another term as the Vice Chairman of the Mathematical Pharmacology Professional Committee of China during the symposium.
</div>
<div align="justify">The symposium was financially supported by Pfizer, Janssen, Roche, Amgen, ISoP, Bionovo, AB SCIEX, Neotrident and other famous domestic and foreign companies. Janssen sponsored “Poster Excellence Award” to encourage meritorious and talented young scientists. 
This conference was unanimously acknowledged and highly appreciated by audiences for high-profile experts, innovative topics and heated discussions. ISQP also provided a platform for discipline construction, academic exchange, and talent cultivation, and will have a positive impact on Pharmacometrics, new drug research and development in China.</div>
</ul>
                        <span><a href="javascript:if(confirm(%27http://www.htbr.cn/ISQP/default_en.asp  \n\nThis file was not retrieved by Teleport Pro, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?%27))window.location=%27http://www.htbr.cn/ISQP/default_en.asp%27" tppabs="http://www.htbr.cn/ISQP/default_en.asp" style="color:#0053A6;background:none">Learn More</a></span>
                        <br>
					</div>      
				</div>
		  </div>			<div class="body">
				<div class="services">
					<div>
						<div>
							<div>
							  <h4 style="color:#006000;font-size:28px;margin:5px 0 10px;padding: 0 0 10px; text-transform:none">Publication (recent five years, part)</h4>
                              <hr>
								<ol>
								  <li>
								    <p align="left"> Cheng,  Xiaoliang; Zhou, Tianyan; Li, Bo; Li, Mengyao; Li, Liang; Li, Zaiquan; Lu, Wei,  Methotrexate synergizes with 5-aminoimidazole-4-carboxamide riboside in  inhibiting cancer cell proliferation and increases  5-aminoimidazole-4-carboxamide riboside and its active metabolite in tumors, 2013,  Acta Pharmacologica Sinica, 34(7): 951-959, First author supported by Pfizer</p>
								  </li>
								  <li>
  <p align="left"> Bi,  Shanshan; Deng, Chenhui; Zhou, Tianyan; Guan, Zheng; Li, Liang; Li, Hanqing;  Zhang, Liping; Yang, Lu; Lu, Wei, Remifentanil–sevoflurane interaction models  of circulatory response to laryngoscopy and circulatory depression, 2013, British  Journal of Anaesthesia, 110(5): 729-740, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Cheng,  Xiaoliang; Guo, Liping; Li, Zaiquan; Li, Liang; Zhou, Tianyan, Lu, Wei, A HPLC  method for simultaneous determination of 5-aminoimidazole-4-carboxamide  riboside and its active metabolite 5-aminoimidazole-4-carboxamide ribotide in  tumor-bearing nude mice plasma and its application to pharmacokinetics study, 2013,  Journal of Chromatography B, 915–916: 64–70, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Li, Mengyao;  Li, Hanqing; Cheng, Xiaoliang;  Wang,  Xipei; Li, Liang; Zhou, Tianyan. Lu, Wei, Preclinical Pharmacokinetic/Pharmacodynamic  Models to Predict Schedule-Dependent Interaction Between Erlotinib and  Gemcitabine, 2013, Pharmaceutical Research, 30: 1400-1408</p>
								  </li>
								  <li>
								    <p align="left"> Zhou, Xuan;  Shang, Dewei; Zhang, Tianlan; Li, Liang; Zhou, Tianyan; Lu, Wei, Modeling of  Angiotensin II-Angiotensin-(1-7) Counterbalance in Disease Progression in  Spontaneously Hypertensive Rats Treated With/Without Perindopril, 2012, Pharmacologic  Research, 66: 177-184, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Li, Xingang;  Li, Liang; Wang, Xipei; Ren, Yupeng; Zhou, Tianyan; Lu, Wei, Application of  Model-Based Methods to Characterize Exenatide-Loaded Double-Walled  Microspheres: In Vivo Release, Pharmacokinetic/Pharmacodynamic Model, and In  Vitro and In Vivo Correlation, 2012, Journal of Pharmaceutical Sciences, 101(10):  3946-3961, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Xu,  Jiaojiao; Chen, Ye; Li, Liang; Li, Zaiquan; Wang, Chenai; Zhou, Tianyan, Lu,  Wei, An improved HPLC method for the quantitation of 3′-phosphoadenosine 5′-phosphate  (PAP) to assay sulfotransferase enzyme activity in HepG2 cells, 2012, Journal  of Pharmaceutical and Biomedical Analysis, 62: 182-186</p>
								  </li>
								  <li>
								    <p align="left"> Ji, Xiwei;  Chen, Ye; Li, Runtao; Zhou, Tianyan ; Lu, Wei, A high-sensitivity LC-MS/MS  method for determination of 4-methyl-piperazine-1-carbodithioc acid 3-cyano-3,  3-diphenylpropyl ester hydrochloride in rat plasma and its application to  pharmacokinetics study, 2012, Biomedical Chromatography, 26: 1196-1201</p>
								  </li>
								  <li>
								    <p align="left"> Li, Xingang;  Li, Liang; Zhou, Xuan; Chen, Ye; Ren, Yupeng; Zhou, Tianyan; Lu, Wei, Pharmacokinetic/  pharmacodynamic studies for exenatide in diabetic rats, 2012, Acta Pharmacologic  Sinica, 33: 1379-1386, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Li, Liang;  Li, Zaiquan; Deng, Chenhui; Ning, Miaoran; Li, Hanqing; Bi, Shanshan; Zhou,  Tianyan and Lu, Wei, A Mechanism-based Pharmacokinetic/Pharmacodynamic Model  for CYP3A1/2 Induction by Dexamethasone in Rats, 2012, Acta Pharmacologic  Sinica, 33: 127-136, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Wang,  Xipei; Shang, Dewei; Ribbing, Jakob; Ren, Yupeng; Deng, Chenhui; Zhou, Tianyan;  Guo, Feng; Lu, Wei, Placebo effect model in asthma clinical studies–Longitudinal  meta-analysis of forced expiratory volume in one second.  Pharmacology, 2012, European Journal of  Clinical Pharmacology, 68: 1157–1166, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Li LJ,  &nbsp;Shang DW, Li WB, Guo W, Wang XP, Ren YP, Li AN, Fu PX, Ji SM, Lu W, Wang  CY, Population Pharmacokinetics of Clozapine and its Main Metabolite  Norclozapine in Chinese Patients with Schizophrenia, 2012, Acta Pharmacologic  Sinica, 33(11): 1409-1416, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Wu, Ke-hua;  Guo, Tao; Deng, Chen-hui; Guan, Zheng; Li, Liang; Zhou, Tian-yan; Lu, Wei, Population  pharmacokinetics of modafinil acid and estimation of the metabolic conversion  of modafinil into modafinil acid in 5 major ethnic groups of China, 2012, Acta Pharmacologic  Sinica, 33(11): 1401-1408</p>
								  </li>
								  <li>
								    <p align="left"> Wenqian  Chen, Yanqing Zhang, Junbo Xie, Tianyan Zhou, Wei Lu, SIMULTANEOUS  DETERMINATION OF SIX PHENOLIC COMPOUNDS IN GUANXIN II PRESCRIPTION BY  HPLC/MS/MS, 2012, Journal of Liquid Chromatography &amp; Related Technologies, 35:  757–767</p>
								  </li>
								  <li>
								    <p align="left"> He DK, Wang  L, Qin J, Zhang S, Lu W, Li L, Zhang JM, Bao WQ, Song XQ, Liu HT, Population  pharmacokinetics of lamotrigine in Chinese children with epilepsy, 2012, Acta  Pharmacol Sinica, 33(11): 1417-23</p>
							      </li>
								  <li>
								    <p align="left"> Wang HL,  Yang L, Guo XY, Zhang LP, Bi SS, Lu W, Response surface analysis of  sevoflurane-remifentanil interactions on consciousness during anesthesia, 2012,  Chin Med J (Engl), 125(15): 2682-7</p>
								  </li>
								  <li>
								    <p align="left"> Wang YH,  Wang L, Lu W, Shang DW, Wei MJ, Wu Y, Population pharmacokinetics modeling of  levetiracetam in Chinese children with epilepsy, 2012, Acta Pharmacol Sinica, 33(6):  845-51, </p>
								  </li>
								  <li>
								    <p align="left"> LU He-qi,  LU Wei, WANG Zhong, ZHANG Ling, WEI Ya-chuan, Applications of  Pharmacokinetic/pharmacodynamic in prescriptions related research of  traditional Chinese medicine, 2012, Chinese Journal of Basic Medicine in  Traditional Chinese Medicine, 18(9): 1040-1043</p>
								  </li>
								  <li>
								    <p align="left"> GUO Tao,  SUN Zuo-ming, GUAN Zheng, XIA Dong-ya, YANG Lu, ZHOU Tian-yan, LU Wei, Population  Pharmacokinetics of Omeprazole in Healthy Volunteers of Different Nationalities  in China by NONMEM, 2012, Pharmaceutical Journal of Chinese People&rsquo;s Liberation  Army, 28(5): 392-396</p>
								  </li>
								  <li>
								    <p align="left"> LIU Jing,  SHANG De-wei, REN Yu-peng, TIAN Gan-zhong, XU Jiao-jiao, ZHOU Tian-yan, LU Wei,  Population Pharmacokinetics of Ambroxol Hydrochloride in Chinese Healthy Male  Subjects, 2012, Chinese Pharmaceutical Journal, 47(3): 218-223</p>
								  </li>
								  <li>
								    <p align="left"> WANG  Hui-ling, YANG Lu, ZHANG Li-ping, GUO Xiang-yang, BI Shan-shan, LU Wei, Pharmacodynamic  interaction between sevoflurane and remifentanil regarding tolerance of  responses to electrical tetanus stimuli, 2012, Chinese Journal of New Drugs, 21(9):  1020-1026</p>
								  </li>
								  <li>
								    <p align="left"> Ye Chen,  Han-Qing Li, Jiao-Jiao Xu, Xiang-Fei Jiu, Chen-Hui Deng, Xin-Gang Li, Liang Li,  Xiao-Qing Xu, Tian-Yan Zhou, Wei Lu, Determination of metformin in diabetic rat  plasma by an improved ion-pair high-performance liquid chromatography:  application to a pharmacokinetic study, 2012, Journal of Chinese Pharmaceutical  Sciences, 21(3): 211-218</p>
								  </li>
								  <li>
								    <p align="left"> Peng Xu,  Wen-Si Lin, Chuan-Jun Zhu, Ke-Lin Liu, Ying Chang, Yu-Xin Cui, Xiao-Mei Ling,  Wei Lu, Identification of dimethylamphetamine in a suspect exhibit, 2012, Journal  of Chinese Pharmaceutical Sciences, 21(4): 355-359</p>
								  </li>
								  <li>
								    <p align="left"> Meng-Yao  Li, Qiong Wu, Han-Qing Li, Miao-Ran Ning, Ye Chen, Liang Li, Tian-Yan Zhou, Wei  Lu, A sensitive LC-MS/MS method to determine the concentrations of erlotinib  and its active metabolite OSI-420 in BALB/c nude mice plasma simultaneously and  its application to a pharmacokinetic study, 2012, Journal of Chinese  Pharmaceutical Sciences, 21(4): 296-303</p>
								  </li>
								  <li>
								    <p align="left"> WANG  Ying-hui, WANG Li, LU Wei, WEI Min-ji, WU Ye, SHANG De-wei, WANG Yun-xiu, Population  pharmacokinetic analysis of levetiracetam in Chinese children with epilepsy, 2012,  Chinese Journal of Practical Pediatrics, 27(7): 517-522</p>
								  </li>
								  <li>
								    <p align="left"> XU Peng, LI  Xiaona, LIU Kelin, LING Xiaomei, LU Wei, UFLC DETERMINATION OF THE CONTENT OF  JWH-018 IN NEW &ldquo;K2&rdquo; SPICE, 2012, Chinese Journal of Drug Dependence, 21(4):  282-285</p>
								  </li>
								  <li>
								    <p align="left"> Chen,  Wenqian; Zhang, Yanqing; Xie, Junbo; Zhou, Tianyan; Lu, Wei, Antagonism  activity against acute myocardial ischemia of paeoniflorin and its  pharmacokinetic/ pharmacodynamic(PK/PD) modeling in rats, 2011, Journal of  Medicinal Plants Research, 5(29): &nbsp;6496-6501</p>
								  </li>
								  <li>
								    <p align="left"> Zhang D,  Wang Z, Zhao X, Lu W, Gu J, Cui Y, Pharmacokinetics, pharmacodynamics,  tolerability and safety of single doses of bivalirudin in healthy chinese  subjects, 2011, Biol Pharm Bull, 34(12): 1841-8</p>
								  </li>
								  <li>
								    <p align="left"> Ren YP,  Deng CH, Wang XP, Zhou TY, Lu W, Comparison study of model evaluation methods:  normalized prediction distribution errors vs. visual predictive check, 2011, Acta  Pharmaceutical Sinica, 46(9): 1123-31, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Deng CH,  Zhang GM, Bi SS, Zhou TY, Lu W, The therapeutic drug monitoring network server  of tacrolimus for Chinese renal transplant patients, 2011, Acta Pharmaceutical  Sinica, 46(7): 828-33, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Shang D,  Wang X, Zhao X, Huang F, Tian G, Lu W, Zhou T, Simultaneous determination of  nitrendipine and hydrochlorothiazide in spontaneously hypertensive rat plasma  using HPLC with on-line solid-phase extraction, 2011, J Chromatogr B Analyt  Technol Biomed Life Sci, 879(30): 3459-64, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Xiang-Fei  Jiu, De-Wei Shang, Ye Chen, Xin-Gang Li, Xiao-Meng Wan, Tian-Yan Zhou, Wei Lu, A  high performance liquid chromatography method for the quantitative  determination assay of sitagliptin in rat plasma and its application in  pharmacokinetics study, 2011, Journal of Chinese Pharmaceutical Sciences, 20(1):  63-69</p>
								  </li>
								  <li>
								    <p align="left"> LIU Ling,  HUA Ying, ZHAO Wei-hong, LU Xin-tian, MA Yue-hong, LU Wei-wei, DU Jun-bao, Lu  Wei, Population pharmacokinetics of high-dose methotrexate in childhood  lymphoid malignancies, 2011, Chinese Journal of Practical Pediatrics, 26(2):  104-108</p>
								  </li>
								  <li>
								    <p align="left"> Han-Qing  Li, Ye Chen, Zai-Quan Li, Chen-Hui Deng, Liang Li, Shan-Shan Bi, Meng-Yao Li,  Tian-Yan Zhou, Wei Lu, high performance liquid chromatography method for the  quantitative determination of erlotinib in the plasma of tumor bearing BALB/c  nude mice and its application in a pharmacokinetic study, 2011, Journal of  Chinese Pharmaceutical Sciences, 20(3): 245-252</p>
								  </li>
								  <li>
								    <p align="left"> SHI Jie,  GUO Tao, XIA Dong-ya, XU Ning-ning, DENG Chen-hui, BI Shan-shan, ZHOU Tian-yan,  LU Wei, Population Pharmacokinetics of Zolpidem Tartrate Tablets in Healthy  Volunteers of Five Different Nationalities in China, 2011, Chinese  Pharmaceutical Journal, 46(11): 850-857</p>
								  </li>
								  <li>
								    <p align="left"> Liang Li,  Zai-Quan Li, Han-Qing Li, Shan-Shan Bi, Jiao-Jiao Xu, Bo Li, Tian-Yan Zhou, Wei  Lu, Absolute quantification of induced mRNA expression of CYP3A1 and CYP3A2 in  rat liver using quantitative real time PCR assay, 2011, Journal of Chinese  Pharmaceutical Sciences, 20(6): 597-603, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Xu CY, Wu  XM, Jiang JY, Lu W, Effect of remifentanil on propofol pharmacokinetics with  target controlled infusion in elderly patients, 2010, Journal of Peking  University (Health Science), 42(6): 734-8, </p>
								  </li>
								  <li>
								    <p align="left"> Yang L,  Wang HL, Zhang LP, Bi SS, Lu W, Yang BX, Guo XY, Population pharmacokinetics of  rocuronium delivered by target-controlled infusion in adult patients, 2010, Chin  Med J (Engl), 123(18): 2543-7</p>
								  </li>
								  <li>
								    <p align="left"> Yang L, Wei  B, Zhang LP, Bi SS, Lu W, Guo XY, Pharmacodynamic interaction between propofol  and remifentanil on the tolerance response to electrical tetanus stimuli, 2010,  Journal of Peking University (Health Science), 42(5): 547-53</p>
								  </li>
								  <li>
								    <p align="left"> ZHANG  Xing-yi, CHEN Da-wei, LU Wei, Comparison of several statistic designs in the  development of ligustrazine hydrochloride(TMPH) sustained release formulations,  2010, Chinese Journal of New Drugs, 19(5): 365-371</p>
								  </li>
								  <li>
								    <p align="left"> SHANG  De-wei, WANG Xi-pei, DENG Chen-hui, BI Shan-shan, GUAN Zheng, ZHOU Tian-yan, LU  Wei, Application of pharmacometrics in drug development and therapeutic drug  monitoring, 2010, Journal of China Pharmaceutical University, 41(1): 91-96, First  author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> ZHANG  Xing-yi, ZHAO Ya-nan, WANG Yue-ran, ZHANG Qiang, LU Wei, Establish the  population pharmacokinetics model of azithromycin in Chinese healthy volunteers,  2010, The Chinese Journal of Clinical Pharmacology, 26(2): 106-110</p>
								  </li>
								  <li>
								    <p align="left"> DENG  Chen-hui, ZHANG Guan-min, BI Shan-shan, SHANG De-wei, ZHOU Tian-yan, LU Wei, Therapeutic  Drug Monitoring Software of Tacrolimus for Chinese Renal Transplant Patients, 2010,  Chinese Pharmaceutical Journal, 45(10): 775-780, First author supported by  Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> SUN  Chuan-jiang, GU Miao-ning, LIANG Li-li, BI Shan-shan, LU Wei, Opioid-Volatile  pharmacodynamic interaction:a response surface analysis with sevoflurane and  sufentanil as prototypes, 2010, Chinese Journal of New Drugs, 19(22): 2070-2076</p>
								  </li>
								  <li>
								    <p align="left"> Guan Z,  &nbsp;Zhang GM, &nbsp;Ma P, &nbsp;Liu LH, &nbsp;Zhou TY, &nbsp;Lu W, Application  of Fourier amplitude sensitivity test in Chinese healthy volunteer population  pharmacokinetic model of tacrolimus, 2010, Acta Pharmaceutical Sinica, 45(7):  883-90</p>
								  </li>
								  <li>
								    <p align="left"> Peng Zhen,  Xiao-Jing Fan, Liang Ma, Zheng Guan, Wei Lu, Xin Hu, Application of fuzzy  analytical method in the optimization of liposome preparation by orthogonal  experiments, 2009, Journal of Chinese Pharmaceutical Sciences, 18(1): 37-42</p>
								  </li>
								  <li>
								    <p align="left"> XU  Ning-ning, CHANG Xin-yu, GUO Tao, XIA Dong-ya, WU Ke-hua, DENG Chen-hui, BI  Shan-shan, ZHOU Tian-yan, LU Wei, Population Pharmacokinetics of Tinidazole in  Five Different Ethnic Populations of China, 2009, Chinese Pharmaceutical  Journal, 44(9): 692-698</p>
								  </li>
								  <li>
								    <p align="left"> Zhao Y,  &nbsp;Wu XM, &nbsp;Duan JL, &nbsp;Sheng XY, &nbsp;Liu W, &nbsp;Lu W,  &nbsp;Zhang LP, &nbsp;Xu CY, Pharmacokinetics of sufentanil administered by  target-controlled infusion in Chinese surgical patients, 2009, Chin Med J  (Engl), 122(3): 291-5</p>
								  </li>
								  <li>
								    <p align="left"> Zhang LP,  &nbsp;Yang L, &nbsp;Bi SS, &nbsp;Lu W, &nbsp;Zhang XH, &nbsp;Zhai SD,  &nbsp;Duan LP, Population pharmacokinetics of remifentanil in patients  undergoing orthotopic liver transplantation, 2009, Chin Med J (Engl), 122(9):  1032-8</p>
								  </li>
								  <li>
								    <p align="left"> Zhang Y,  &nbsp;Xie J, &nbsp;Chen WQ, &nbsp;Zhou TY, &nbsp;Lu W, Development of a sensitive  high-performance liquid chromatographic method with simple extraction for  simultaneous determination of huperzine A and huperzine B in the species  containing lycopodium alkaloids, 2009, J AOAC Int, 92(4): 1060-3</p>
								  </li>
								  <li>
								    <p align="left"> Zhao Y,  &nbsp;Duan JL, &nbsp;Wu XM, &nbsp;Jiang JY, &nbsp;Lu W, &nbsp;Zhang LP,  &nbsp;Wang J, &nbsp;Meng XL, &nbsp;Xu CY, &nbsp;Jia DL, &nbsp;Liu W,  &nbsp;Sheng XY, Two-stage analysis of pharmacokinetics of sufentanil  administered by target-controlled infusion in Chinese patients, 2009, Chin Med  J (Engl), 122(17): 1979-84</p>
								  </li>
								  <li>
								    <p align="left"> Qiu XW,  &nbsp;Fu PX, &nbsp;Wang CY, &nbsp;Liu M, &nbsp;Zhou TY, &nbsp;Lu W, Population  pharmacokinetics research of clozapine in Chinese schizophrenic patients, 2009,  Acta Pharmaceutical Sinica, 44(7): 785-92</p>
								  </li>
								  <li>
								    <p align="left"> ZHANG  Xing-yi, CHEN Da-wei, JIN Jie, LU Wei, Artificial neural network parameters optimization  software and its application in the design of sustained release tablets, 2009, Acta  Pharmacologic Sinica, 10: 1156-64</p>
								  </li>
								  <li>
								    <p align="left"> Zhang  yanqing, Xie Junbo, Chen Wenqian, Deng Chenhui, Jiu Xiangfei, Zhou Tianyan, Lu  Wei, Optimization the preparation of huperzine liposome by orthogonal test, 2009,  Chinese Traditional and Herbal Drugs, 40(6): 896-98</p>
								  </li>
								  <li>
								    <p align="left"> LIU Xiao,  ZHANG Xiang-lin, ZHANG Lei, LI Peng-mei, LI Kai-peng, LU Wei, A Validation  Study of Three Selected Methods Routinely Used For Measurement of Cyclosporine  A, 2009, Chinese Pharmaceutical Journal, 44(10): 790-94</p>
								  </li>
								  <li>
								    <p align="left"> Zhang CY,  Gu J, Li YZ, Lu W, Population pharmacokinetics of high-dose methotrexate  administered in 329 children with acute lymphoblastic leukemia, 2008, Journal  of Experimental Hematology, 16(1): 106-10</p>
								  </li>
								  <li>
								    <p align="left"> Zhang S,  &nbsp;Wang L, &nbsp;Lu W, Population pharmacokinetics of lamotrigine in Chinese  children with epilepsy, 2008, Chinese Journal of Contemporary Pediatrics, 10(2):  105-9</p>
								  </li>
								  <li>
								    <p align="left"> Hua Y, Wang  F, Zhao W, Lu W, Zhang H, Li J, Ding J, Lu X, Nonmuscle myosin heavy chain 9  gene mutations related disease: a family report, 2008, Journal of Peking  University (Health Science), 40(2): 160-4</p>
								  </li>
								  <li>
								    <p align="left"> Liu YF,  &nbsp;Yang XW, &nbsp;Lu W, &nbsp;Xin XL, Determination and pharmacokinetic  study of tussilagone in rat plasma by RP-HPLC method, 2008, Biomed Chromatogr, 22(11):  1194-200</p>
								  </li>
								  <li>
								    <p align="left"> Zhang GM,  &nbsp;Li L, &nbsp;Chen WQ, &nbsp;Bi SS, &nbsp;Liu X, &nbsp;Zhang XL, &nbsp;Lu W,  Population pharmacokinetics of tacrolimus in Chinese renal transplant patients,  2008, Acta Pharmaceutical Sinica, 43(7): 695-701</p>
								  </li>
								  <li>
								    <p align="left"> Hua Y,  &nbsp;Zhao WH, &nbsp;Lu XT, &nbsp;Yang LH, &nbsp;Lu W, Investigation on  individualized adjustment of target range of high-dose methotrexate, 2008, Chinese  Journal of Pediatrics, 46(3): 203-8</p>
								  </li>
								  <li>
								    <p align="left"> ZUO  Ying-xi, LI Liang, LU Wei, LIU Gui-lan, JIA Yue-ping, Determination of  1-β-D-arabinofuranosylcytosine incorporation into DNA in vivo by HPLC, 2008, Chinese  Journal of Hospital Pharmacy, 28(9): 718-21</p>
								  </li>
								  <li>
								    <p align="left"> LI Liang,  GUAN Zheng, MA Xin, JIU Xiang-fei, LU Wei, Simultaneous Determination of  Dexamethasone, Testosterone and 6β-OH Testosterone in William&rsquo;s Medium E, 2008,  Chinese Pharmaceutical Journal, 11: 870-74, First author supported by Pfizer</p>
								  </li>
								  <li>
								    <p align="left"> Wen-Qian  Chen, Yu-Hui Hu, Yan-Qing Zhang, Guan-Min Zhang, Liang Li, Wei-Ning Yang, Wei  Lu, Population pharmacokinetics of paeoniflorin in guanxin Ⅱ prescription, 2008, Journal of Chinese  Pharmaceutical Sciences, 1: 55-63</p>
								  </li>
								  <li>
								    <p align="left"> Guan-Min  Zhang, Wen-Qian Chen, Liang Li, Yu-Hui Hu, Yan-Qing Zhang, Hong Yi, Hua Yang,  Wei Lu, Population pharmacokinetic analysis of baicalin after oral administration  of different Shuang-Huang-Lian formulations to rats, 2008, Journal of Chinese  Pharmaceutical Sciences, 1: 46-54</p>
								  </li>
								  <li>
								    <p align="left"> Yang Lu, Bi  Shanshan, Lu Wei, Yang Baxian, Pharmacodynamic Interactions between  Remifentanil and Sevoflurane during General Anesthesia for Laparoscopic  Operations, 2008, Chinese Journal of Minimally Invasive Surgery, 4: 345-48</p>
								  </li>
								  <li>
								    <p align="left"> SUN Li li,  SI Tian mei, LIU Yi, YANG Qin, ZHAI Suo di, LU Wei, Population pharmacokinetics  of citalopram by NONMEM, 2008, The Chinese Journal of Clinical Pharmacology, 24(2):  151-56</p>
								  </li>
								  <li>
								    <p align="left"> ZHANG  Chun-Yan, GU Jian, LI Yu-Zhen, LU Wei, Population Pharmacokinetics of High-dose  Methotrexate Administered in 329 Children with Acute Lymphoblastic Leukemia, 2008,  Journal of Experimental Hematology, 1: 106-10</p>
								  </li>
								  <li>
							      <p align="left"> ZHOU YING,  CUI Yi-MIN, LU Wei, Individual medicine of cyclosporine: a case report, 2008, Chinese  Pharmaceutical Journal, 24: 1925-26</p></li>
								  <li>
								    <p align="left">GUAN Zheng, BI Shan-shan, YANG Lu, ZHANG Li-ping, ZHOU Tian-yan, LU  Wei, Progress in the study of response surface modeling in investigation of  drug-drug interaction in anesthetic drugs, 2008, Acta Pharmaceutic Sinica, 12:  1171-78 </p>
							      </li>
                              </ol>
                          </div>
						</div>
					</div>
				</div>
			</div>
<div class="footer">
  <div>
    <div>
      <p> Peking University Pharmacometrics Group<br><br>
	  Suite 424, Pharm. Building, 38# Xueyuan Road, Haidian District<br>Beijing, 100191, China<br>
          <br>
        京ICP备10016721号-1<br>
        京公网安备11010802009438号 </p>
    </div>
    <div>
      <h4>Links</h4>
      <ul>
        <li> <a href="home.html" tppabs="http://www.poppk-beijing.org/home.html">Home</a> </li>
        <li> <a href="PPPEC.html" tppabs="http://www.poppk-beijing.org/PPPEC.html">PMxEC</a> </li>
        <li> <a href="education.html" tppabs="http://www.poppk-beijing.org/education.html">Education</a> </li>
        <li> <a href="research.html" tppabs="http://www.poppk-beijing.org/research.html">Research</a> </li>
        <li> <a href="group.html" tppabs="http://www.poppk-beijing.org/group.html">Group</a> </li>
        <li> <a href="publication.html" tppabs="http://www.poppk-beijing.org/publication.html">Publication</a> </li>
        <li> <a href="cooperation.html" tppabs="http://www.poppk-beijing.org/cooperation.html">Cooperation</a> </li>
        <li> <a href="TDM.html" tppabs="http://www.poppk-beijing.org/TDM.html">TDM</a> </li>
        <li> <a href="photo.html" tppabs="http://www.poppk-beijing.org/photo.html">Photo</a> </li>
        <li> <a href="home-cn.html" tppabs="http://www.poppk-beijing.org/home-cn.html">中文</a> </li>
      </ul>
    </div>
    <div class="connect">
      <h4>Links</h4>
      <a style="font-size:12px; margin:5px 0px;" href="javascript:if(confirm(%27http://www.pku.edu.cn/  \n\nThis file was not retrieved by Teleport Pro, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?%27))window.location=%27http://www.pku.edu.cn/%27" tppabs="http://www.pku.edu.cn/">Peking University</a> <a style="font-size:12px;  margin:5px 0px; line-height: 12px;" href="javascript:if(confirm(%27http://www.bjmu.edu.cn/  \n\nThis file was not retrieved by Teleport Pro, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?%27))window.location=%27http://www.bjmu.edu.cn/%27" tppabs="http://www.bjmu.edu.cn/">Peking University Health Science Center</a> <a style="font-size:12px;  margin:5px 0px; line-height: 12px" href="javascript:if(confirm(%27http://www.cpa.org.cn/  \n\nThis file was not retrieved by Teleport Pro, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?%27))window.location=%27http://www.cpa.org.cn/%27" tppabs="http://www.cpa.org.cn/">Chinese Pharmaecutical Association</a> <a href="javascript:if(confirm(%27http://www.htbr.cn/isqp/  \n\nThis file was not retrieved by Teleport Pro, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?%27))window.location=%27http://www.htbr.cn/isqp/%27" tppabs="http://www.htbr.cn/isqp/">ISQP</a> </div>
  </div>
</div>
	  </div>
	</div>
<div style="display:none"><script src="../v7.cnzz.com/stat.php-id=155540&web_id=155540.js" tppabs="http://v7.cnzz.com/stat.php?id=155540&web_id=155540" language='JavaScript' charset='gb2312'></script></div>
</body>
</html>